Feb 9 (Reuters) – Shield Therapeutics PLC: * SHIELD THERAPEUTICS – FDA GRANTS ADDITIONAL EXCLUSIVITY FOR ACCRUFER * SHIELD THERAPEUTICS : EXCLUSIVITY REMAINS IN PLACE UNTIL 19 DEC 2028 IN ADDITION TO ACCRUFER/FERACCRU PATENT COVERAGE VALID UNTIL MID-2030S Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
We asked specialists which is best, tampons or a menstrual cup, in terms of environmental…
Mumbai (Maharashtra) [India], August 19: The Maharashtra Flat Owners Welfare Association (MFOWA) on Tuesday held…
Hyderabad (Telangana) [India], August 19: This Raksha Bandhan, Country Club Hospitality & Holidays Limited is celebrating the…
Mumbai (Maharashtra) [India], August 19: B-Right Real Estate Group outlined its long-term roadmap at its…
Thane, (Maharashtra) [India], August 19: Decorb Vibes, an Indian premium décor and luxury lighting brand,…
UK-Based Specialist Crypto Insurance Programme Designed to Cover Token Default, Platform Default, Crime & Theft,…